Immunologic control of ovarian cancer.
Zighelboim
J
J
Department of Microbiology, Jonsson Comprehensive Cancer Center, UCLA School of Medicine.
Nio
Y
Y
Berek
J S
JS
Bonavida
B
B
D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007370:Interferon Type I / Q000627:therapeutic use; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D010529:Peritoneal Cavity / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology
D007370:Interferon Type I; D007376:Interleukin-2